Tocira 400mg Injection

Product Details

Tocira 400mg Injection also known as Actemra contains the active ingredient tocilizumab, a monoclonal antibody used in the treatment of autoimmune conditions such as rheumatoid arthritis and systemic juvenile idiopathic arthritis (SJIA). Tocilizumab works by targeting and inhibiting the interleukin-6 (IL-6) receptor, a protein involved in inflammation and immune responses. By blocking IL-6 signaling, Tocira reduces inflammation, alleviating symptoms such as pain and swelling. It has also been used in certain inflammatory conditions and cytokine release syndrome (CRS) associated with certain immunotherapy treatments.

Uses:

• Treatment of moderate to severe rheumatoid arthritis in adults, often in combination with other disease-modifying antirheumatic drugs (DMARDs).
• Management of systemic juvenile idiopathic arthritis (SJIA) and polyarticular juvenile idiopathic arthritis (PJIA) in children.
• Indicated for treating cytokine release syndrome (CRS) due to chimeric antigen receptor (CAR) T-cell therapy.
• May be used for other inflammatory conditions as determined by a healthcare provider.

Side Effects:

• Common side effects: upper respiratory tract infections, headaches, increased liver enzymes, and high blood pressure.
• Serious side effects: serious infections (e.g., tuberculosis), liver problems, gastrointestinal perforations, and allergic reactions. It is important to monitor for infections and seek immediate medical attention if symptoms worsen.

Key Features:

• Contains tocilizumab, a monoclonal antibody that blocks IL-6 activity.
• Reduces inflammation and immune system overactivity in autoimmune diseases.
• Effective for rheumatoid arthritis, juvenile arthritis, and cytokine release syndrome.
• Can be administered as an intravenous injection under medical supervision.

FAQ:

1. How does Tocira 400mg Injection work?
   Tocira inhibits the interleukin-6 (IL-6) receptor, reducing inflammation and modulating immune system responses in autoimmune and inflammatory diseases.
2. Who can use Tocira?
   It is prescribed for adults with moderate to severe rheumatoid arthritis and children with juvenile idiopathic arthritis, among other conditions, as recommended by a healthcare provider.
3. What precautions should I take while using Tocira?
   Regular monitoring for infections, liver function, and blood parameters is essential. Inform your healthcare provider of any history of infections, liver disease, or gastrointestinal problems.

References:

1. Roche Pharmaceuticals. “Actemra (tocilizumab) Injection.” [Accessed on 6 Nov 2024]. Available from: https://www.drugs.com/actemra.html
2. European Medicines Agency (EMA). “Tocilizumab Product Information.” [Accessed on 6 Nov 2024]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK570644/